The Role of PD-1 and PD-L1
Julie R. Brahmer, MD, explains the role of the PD-1 pathway and the ligands PD-L1 and PD-L2 in the regulation of the immune system.
Julie R. Brahmer, MD, from Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, explains the role of the PD-1 pathway and the ligands PD-L1 and PD-L2 in the regulation of the immune system.
Clinical Pearls
- The program death 1 (PD-1) pathway is a checkpoint pathway that controls immune response in the body to prevent extreme inflammation or other problems during illness
- PD-1 is a receptor on a T cell while its ligand, PD-L1, is expressed on peripheral tissues or tumor cells. PD-L2, another ligand, is also thought to be present on antigen-presenting cells or tumor cells, though research is ongoing
- When the T cell binds to one of its ligands, it deactivates the T cell. This protects the tumor from the body’s immune system
- When that response is blocked, the T cell can remain active and kill the tumor
Recent Videos
Related Content
Survivorship Care Promotes Evidence-Based Approaches for Quality of Life and Beyond
March 21st 2025Article
Frank J. Penedo, PhD, explains the challenges of survivorship care for patients with cancer and how he implements programs to support patients’ emotional, physical, and practical needs.
Read More
